Borje Ljungberg
Overview
Explore the profile of Borje Ljungberg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
234
Citations
8224
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lind A, Mazin Hashim B, Hagman M, Holst S, Karlsson Rosenblad A, Ljungberg B, et al.
Scand J Urol
. 2025 Mar;
60:66-72.
PMID: 40079736
Objective: To analyse the budget impact of adopting routine renal tumour biopsy (RTB) prior to decision on surgical treatment for clinical T1 renal tumours in Sweden. Material And Methods: This...
2.
Karlsson Rosenblad A, Mazin Hashim B, Lindblad P, Ljungberg B
World J Urol
. 2025 Mar;
43(1):157.
PMID: 40063140
No abstract available.
3.
Karlsson Rosenblad A, Mazin Hashim B, Lindblad P, Ljungberg B
World J Urol
. 2024 Nov;
42(1):621.
PMID: 39495377
No abstract available.
4.
Mazin Hashim B, Chabok A, Ljungberg B, Ostberg E, Alamdari F
Scand J Urol
. 2024 Sep;
59:141-146.
PMID: 39258576
Objective: To assess the safety and diagnostic accuracy of renal tumour biopsy (RTB) in patients with small renal masses (SRM) and to assess if RTB prevents overtreatment in patients with...
5.
Karlsson Rosenblad A, Mazin Hashim B, Lindblad P, Ljungberg B
World J Urol
. 2024 Aug;
42(1):474.
PMID: 39112814
Purpose: To examine associations between ablative therapy (AT) and partial nephrectomy (PN) and the occurrence of local recurrence (LR), distant metastatic recurrence (DMR) and all-cause mortality in a nation-wide real-world...
6.
Akerlund J, Ljungberg B, Lundstam S, Peeker R, Holmberg E, Mansson M, et al.
Scand J Urol
. 2024 May;
59:109-116.
PMID: 38747153
Objective: Several risk factors for end-stage renal disease (ESRD), in patients undergoing surgical treatment for renal cell carcinoma (RCC), have been suggested by others. This study aimed to investigate such...
7.
Sitaram R, Ljungberg B
Ups J Med Sci
. 2024 Apr;
129.
PMID: 38571885
Objectives: This study aimed to assess the cellular localization and expression levels of hypoxia-inducible factor (HIF) -α proteins (specifically HIF-1α, HIF-2α, and HIF-3α) that play a role in the hypoxia...
8.
Iisager L, Ahrenfeldt J, Donskov F, Ljungberg B, Bex A, Lund L, et al.
BMC Cancer
. 2024 Feb;
24(1):260.
PMID: 38402173
Background: Primary tumor removal by cytoreductive nephrectomy in synchronous metastatic renal cell carcinoma patients has been investigated in the context of various treatment regimens. Two randomized controlled trials investigated the...
9.
Kroger Dahlin B, Hlodan J, Ghaffarpour R, Ljungberg B
Scand J Urol
. 2024 Feb;
59:26-30.
PMID: 38358280
Background: Surgical strategy in renal cell carcinoma (RCC) is considered based on the renal function. Partial nephrectomy (PN) preserves kidney function better than radical nephrectomy (RN), lowering risk of chronic...
10.
Akerlund J, Sundqvist P, Ljungberg B, Lundstam S, Peeker R, Mansson M, et al.
Scand J Urol
. 2023 Aug;
58:38-45.
PMID: 37605443
Objective: Nationwide register data provide unique opportunities for real-world assessment of complications from different surgical methods. This study aimed to assess incidence of, and predictors for, post-operative complications and to...